Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S
about
Interlaboratory comparison of three multiplexed bead-based immunoassays for measuring serum antibodies to pneumococcal polysaccharidesMethod for simultaneous measurement of antibodies to 23 pneumococcal capsular polysaccharidesSalivary antibodies induced by the seven-valent PncOMPC conjugate vaccine in the Finnish Otitis Media Vaccine Trial.Use and clinical interpretation of pneumococcal antibody measurements in the evaluation of humoral immune functionComparison of a new multiplex binding assay versus the enzyme-linked immunosorbent assay for measurement of serotype-specific pneumococcal capsular polysaccharide IgGOptimization and application of a multiplex bead-based assay to quantify serotype-specific IgG against Streptococcus pneumoniae polysaccharides: response to the booster vaccine after immunization with the pneumococcal 7-valent conjugate vaccineKinetics and avidity of antibodies evoked by heptavalent pneumococcal conjugate vaccines PncCRM and PncOMPC in the Finnish Otitis Media Vaccine Trial.Assessment of antibody response elicited by a 7-valent pneumococcal conjugate vaccine in pediatric human immunodeficiency virus infection.Evaluation of pneumococcal polysaccharide immunoassays using a 22F adsorption step with serum samples from infants vaccinated with conjugate vaccinesHyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial.Effects of absorption with pneumococcal type 22F polysaccharide on maternal, cord blood, and infant immunoglobulin G antipneumococcal polysaccharide antibodies.Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharidesSafety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers.Utilization of serologic assays to support efficacy of vaccines in nonclinical and clinical trials: meeting at the crossroadsSpecificities and opsonophagocytic activities of antibodies to pneumococcal capsular polysaccharides in sera of unimmunized young children.An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay study.Assignment of immunoglobulin G1 and G2 concentrations to pneumococcal capsular polysaccharides 3, 6B, 14, 19F, and 23F in pneumococcal reference serum 89-SF.Use of highly encapsulated Streptococcus pneumoniae strains in a flow-cytometric assay for assessment of the phagocytic capacity of serotype-specific antibodies.Transplacental transmission of serotype-specific pneumococcal antibodies in a Brazilian population.Pneumococcal capsular polysaccharide preparations may contain non-C-polysaccharide contaminants that are immunogenic.A flow cytometric opsonophagocytic assay for measurement of functional antibodies elicited after vaccination with the 23-valent pneumococcal polysaccharide vaccineAre the enzyme immunoassays for antibodies to pneumococcal capsular polysaccharides serotype specific?Serum opsonic activity in infants with sickle-cell disease immunized with pneumococcal polysaccharide protein conjugate vaccine. The Pneumococcal Conjugate Vaccine Study GroupComparison of a classical phagocytosis assay and a flow cytometry assay for assessment of the phagocytic capacity of sera from adults vaccinated with a pneumococcal conjugate vaccine.Are the opsonophagocytic activities of antibodies in infant sera measured by different pneumococcal phagocytosis assays comparable?Repertoire of human antibodies against the polysaccharide capsule of Streptococcus pneumoniae serotype 6B.Age-associated differences in immunoglobulin G1 (IgG1) and IgG2 subclass antibodies to pneumococcal polysaccharides following vaccination.Determination of antibody responses of elderly adults to all 23 capsular polysaccharides after pneumococcal vaccination.Avidity, potency, and cross-reactivity of monoclonal antibodies to pneumococcal capsular polysaccharide serotype 6BImmunologic effects of hydroxyurea in sickle cell anemia.Serotype-related variation in susceptibility to complement deposition and opsonophagocytosis among clinical isolates of Streptococcus pneumoniaeOlder adults have a low capacity to opsonize pneumococci due to low IgM antibody response to pneumococcal vaccinationsAssociation between serotype-specific antibody response and serotype characteristics in patients with pneumococcal pneumonia, with special reference to degree of encapsulation and invasive potential.Pneumococcal vaccination and revaccination of older adults.Association of CD14 promoter polymorphism with otitis media and pneumococcal vaccine responses.Enzyme-linked immunosorbent assay for measuring antibodies to pneumococcal polysaccharides for the PNEUMOVAX 23 vaccine: assay operating characteristics and correlation to the WHO international assayEnzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharidesStandardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells.Establishment of a new human pneumococcal standard reference serum, 007sp.Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults.
P2860
Q23918185-F8BB0D09-28D3-462F-B198-B949E98AC850Q23919991-9A74DF3E-0AB2-4C9C-B66E-EC05EC983FCCQ24812739-44125F7F-7158-4BF4-90AD-5651C87BDC24Q28386770-9EEDEE9C-D9A5-4044-86A6-1EB72985785AQ28392402-B71F255E-D1A1-43A8-B0C9-1E9DB242F35EQ28394642-6996B01D-6C37-480A-8625-7944F954C6BBQ33557154-930FB34A-D5AA-4C5E-9D18-FFDCFC860D60Q33593822-9B759828-01FD-4EC5-874B-399172EB846FQ33613509-51149CD0-2176-4BFF-87E1-A0BF4C268E75Q33788106-68A6F075-9D3B-4970-BD28-8F68F23AB89BQ33856465-C75C3F28-B45B-4F5C-8F7F-711D9FD6AF29Q33867137-120C022F-55AB-4E7B-80FE-06E0911872DEQ33909172-737A362F-CADB-401F-990A-F19FA3D03743Q33916408-2AC7CAAE-D199-4D73-8C4D-5B63C2EA9BF5Q33944443-2DF1962B-E45C-481F-ADF6-BBD90EDB6BFFQ33967266-690B13E8-BE93-4A7C-809C-D696999B22DDQ33997389-06976756-1C96-4B12-86FA-48B60FB663EAQ33997459-BA2E67B9-524E-45C7-A6FA-C58DDE4283CEQ33997525-9816BE2E-D8B7-40D0-9548-1FEB76FCAC3CQ33997738-AAEE4511-8A81-4E66-B4F0-F449D73F54F8Q33997787-A53D2354-6605-4D58-AC5A-117353DB01D1Q33998397-10EC2E44-2673-4DF4-A1AE-5E9FF4C76453Q33998620-B5919412-E8AF-4FF4-BF58-0E0A0C35A66BQ33998938-F9A50B22-6F44-4161-8D5E-E1EF498AC5C9Q33998997-5F5B6A17-22EB-411D-A62B-C5C4495FEA49Q34000570-8C39423C-A276-4250-8CD0-9751F8ECC957Q34001923-AEB34637-F5B1-471E-8F0C-B589066B5193Q34002520-16419A79-AA38-47BE-93B7-D9CDB463516EQ34005631-47B80BCC-FB5C-4284-9088-9E2163EEECB7Q34263125-6F4091F0-6E86-45D7-A79F-FE0BF14AC877Q34309712-76E3D210-9BFF-460D-96B6-85B1172BBDE0Q34484625-769E9E2F-ADF7-4465-9965-6F182FCB2266Q34592974-8ADDBB50-AE69-4339-B14D-5769C1CC8888Q34926870-12321F13-7146-469A-B603-C19690FDE604Q34975040-0CFA2F70-B125-4ABD-A0FD-AF866764ED2FQ34975051-F6EE8A8B-B9DF-4814-BB77-ABA0DF58B5AAQ35139987-B5CEA6AD-0884-457C-A07D-CD1A35C9414CQ35229917-99C00FDA-0DAB-459F-8CFC-48DC977ABEBDQ35271202-B86534BF-4132-4F9F-9064-83574C3A3A7DQ35533941-DF8346CD-356D-4F43-B70F-D61AB64A8DDF
P2860
Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S
description
1995 nî lūn-bûn
@nan
1995 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Assignment of weight-based ant ...... dard reference serum, lot 89-S
@ast
Assignment of weight-based ant ...... dard reference serum, lot 89-S
@en
type
label
Assignment of weight-based ant ...... dard reference serum, lot 89-S
@ast
Assignment of weight-based ant ...... dard reference serum, lot 89-S
@en
prefLabel
Assignment of weight-based ant ...... dard reference serum, lot 89-S
@ast
Assignment of weight-based ant ...... dard reference serum, lot 89-S
@en
P2093
P2860
P1476
Assignment of weight-based ant ...... dard reference serum, lot 89-S
@en
P2093
Quataert SA
Strohmeyer S
P2860
P304
P577
1995-09-01T00:00:00Z